IBO
Impact BioMedicalยทAMEX
--
--(--)
--
--(--)
IBO Profile
Impact Biomedical Inc.
A pharmaceutical research and biomedical intellectual property company
Pharmaceutical
10/16/2018
09/16/2024
American Stock Exchange
2
12-31
Common stock
1400 Broadfield Blvd., Suite 130, Houston, TX 77084
--
Impact BioMedical Inc., a Nevada corporation, was founded on October 16, 2018. The company is a subsidiary of DSS, Inc. The company is committed to discovering, validating and patenting unique science and technology, and jointly developing new products in the field of human health with external partners through licensing, cooperative development, joint ventures and other partnerships.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
